Cardium Therapeutics is a health sciences and regenerative medicine company engaged in acquiring and developing products and businesses that can potentially address significant unmet medical needs and have definable pathways to commercialization, partnering or other monetization. The company’s current portfolio includes the Tissue Repair Company, Cardium Biologics and its in-house MedPodium Health Sciences healthy lifestyle product platform. Consistent with its capital-efficient business model, Cardium continues actively evaluating new technologies and business opportunities. For more information, visit the company’s Web site at www.cardiumthx.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: